User menu

Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies.

Bibliographic reference André, Marc ; Humblet, Yves ; Baudoux, Etienne ; Bron, Dominique ; Canon, Jean-Luc ; et. al. Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies.. In: Transfusion, Vol. 43, no. 1, p. 50-7 (2003)
Permanent URL http://hdl.handle.net/2078.1/29510
  1. Frei E, Cancer Res, 48, 6417 (1988)
  2. Hryniuk W, J Clin Oncol, 4, 1162 (1986)
  3. Philip Thierry, Guglielmi Cesare, Hagenbeek Anton, Somers Renier, Van Der Lelie Hans, Bron Dominique, Sonneveld Pieter, Gisselbrecht Christian, Cahn Jean-Yves, Harousseau Jean-Luc, Coiffier Bertrand, Biron Pierre, Mandelli Franco, Chauvin Franck, Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma, 10.1056/nejm199512073332305
  4. Schmitz N, Dreger P, Linch D.C, Goldstone A.H, Boogaerts M.A, Demuynck H.M.S, Ferrant A, Zander A, Link H, Barge A, Borkett K, Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients, 10.1016/s0140-6736(96)90536-x
  5. FAUCHER C., LE CORROLLER A.G., CHABANNON C., VIENS P., STOPPA A.M., BOUABDALLAH R., CANERLO J., VEY N., GRAVIS G., MOATTI J.A., MARANINCHI D., BLAISE D., Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet Recovery, 10.1089/scd.1.1996.5.663
  6. Beguin Y, Transfusion, 38, 199 (1998)
  7. Snowden J A, Biggs J C, Milliken S T, Fuller A, Staniforth D, Passuello F, Renwick J, Brooks P M, A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis, 10.1038/sj.bmt.1701486
  8. Weaver C. H., Birch R., Greco F. A., Schwartzberg L., McAneny B., Moore M., Oviatt D., Redmond J., George C., Alberico T., Johnson P., Buckner C. D., Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim, 10.1046/j.1365-2141.1998.00573.x
  9. Antman K, J Clin Oncol, 10, 102 (1992)
  10. Bensinger W, J Clin Oncol, 13, 2547 (1995)
  11. Tricot G, Blood, 85, 588 (1995)
  12. Siena S, J Clin Oncol, 18, 1360 (2000)
  13. Schulman KA, J Clin Oncol, 17, 1227 (1999)
  14. Ings S, Blood, 92, 2956 (1999)
  15. Sautois B, Haematologica, 84, 342 (1999)
  16. Russell N H, McQuaker G, Stainer C, Byrne J L, Haynes A P, Stem cell mobilisation in lymphoproliferative diseases, 10.1038/sj.bmt.1701477
  17. Johnston E, J Clin Oncol, 18, 2522 (2000)
  18. Weaver CH, J Clin Oncol, 18, 43 (2000)
  19. Pierelli L, J Clin Oncol, 17, 1288 (1999)
  20. Weaver A, J Clin Oncol, 16, 2601 (1998)
  21. Facon T, Blood, 94, 1218 (1999)
  22. Begley CG, Thromb Haemost, 78, 42 (1997)
  23. Reiffers Josy, Cailliot Christian, Dazey Bernard, Attal Michel, Caraux Jean, Boiron Jean-Michel, Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells, 10.1016/s0140-6736(99)03113-x
  24. McNiece I, Blood, 96, 3001 (2000)